Considerations When Applying Pharmacogenomics to Your Practice.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
01 2021
Historique:
received: 20 08 2019
revised: 24 02 2020
accepted: 17 03 2020
pubmed: 15 12 2020
medline: 20 1 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

Many practitioners who have not had pharmacogenomic education are required to apply pharmacogenomics to their practices. Although many aspects of pharmacogenomics are similar to traditional concepts of drug-drug interactions, there are some differences. We searched PubMed with the search terms pharmacogenomics and pharmacogenetics (January 1, 2005, through December 31, 2019) and selected articles that supported the application of pharmacogenomics to practice. For inclusion, we gave preference to national and international consortium guidelines for implementation of pharmacogenomics. We discuss special considerations important in the application of pharmacogenomics to assist clinicians with ordering, interpreting, and applying pharmacogenomics in their practices.

Identifiants

pubmed: 33308868
pii: S0025-6196(20)30268-8
doi: 10.1016/j.mayocp.2020.03.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-230

Informations de copyright

Copyright © 2020 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Auteurs

Wayne T Nicholson (WT)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN. Electronic address: nicholson.wayne@mayo.edu.

Christine M Formea (CM)

Intermountain Healthcare Department of Pharmacy Services Pharmacy Services, Salt Lake City, UT; Intermountain Precision Genomics, Intermountain Healthcare, St George, UT.

Eric T Matey (ET)

Department of Pharmacy, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN.

Jessica A Wright (JA)

Department of Pharmacy, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN.

Jyothsna Giri (J)

Mayo Clinic Center for Individualized Medicine, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN.

Ann M Moyer (AM)

Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH